Skip to main content
Log in

The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

This systematic review and meta-analysis aimed to evaluate the effectiveness of radioactive iodine (RAI) remnant ablation for thyroid cancer-related outcomes of patients with papillary thyroid microcarcinoma (PTMC).

Methods

A systematic literature search of PubMed, EMBASE OvidSP, and EBSCO was conducted. Studies were selected that provided multivariable analysis of the effectiveness of RAI ablation or provided specific data of a 10 years history of thyroid cancer-related outcomes in patients that presented with PTMC.

Results

Nineteen studies met the inclusion criteria. A multivariable analysis of the effectiveness of RAI ablation for any recurrence or thyroid cancer-related mortality in patients with PTMC was performed in several studies, among which only one study reported a positive result. Furthermore, for PTMC patients treated by total or near-total thyroidectomy (TT/NT), with or without RAI ablative therapy, the meta-analysis suggested that RAI ablation did not decrease the 10 years history of any tumor recurrence (relative risk [RR] 0.96; 95 % confidence interval [CI] 0.63–1.48; P = 0.87), locoregional recurrence (RR 1.15; 95 % CI 0.75–1.76; P = 0.51), distant metastases (RR 0.32; 95 % CI 0.08–1.32; P = 0.11) or thyroid cancer-related mortality (RR 0.76; 95 % CI 0.22–2.63; P = 0.66).

Conclusions

With regard to multivariable analyses, there was almost no positive treatment effect of RAI ablation noted for patients with PTMC. For PTMC patients already treated by TT/NT, incremental RAI ablation may not be beneficial at decreasing the 10 years recurrence of PTMC or incidence of thyroid cancer-related mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Hedinger C, Williams E, Sobin L (1988) Histological typing of thyroid tumours. World Health Organisation histological classification of tumors, 2nd edn. Springer-Verlag, Berlin, pp 9–10

    Book  Google Scholar 

  2. Davies L, Welch HG (2014) Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 140:317–322

    Article  PubMed  Google Scholar 

  3. Arora N, Turbendian HK, Kato MA et al (2009) Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 19:473–477

    Article  PubMed  Google Scholar 

  4. Wartofsky L (2012) Management of papillary microcarcinoma: primum non nocere? J Clin Endocrinol Metab 97:1169–1172

    Article  PubMed  CAS  Google Scholar 

  5. Haymart MR, Banerjee M, Stewart AK et al (2011) Use of radioactive iodine for thyroid cancer. JAMA 06:721–728

    Article  Google Scholar 

  6. Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  7. Pacini F, Castagna MG, Brilli L et al (2012) Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:vii110–vii119

    Article  PubMed  Google Scholar 

  8. Jung TS, Kim TY, Kim KW et al (2007) Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265–274

    Article  PubMed  Google Scholar 

  9. Sawka AM, Thephamongkhol K, Brouwers MA et al (2004) Systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 89:3668–3676

    Article  PubMed  CAS  Google Scholar 

  10. Sacks W, Fung CH, Chang JT et al (2010) The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. Thyroid 20:1235–1245

    Article  PubMed  CAS  Google Scholar 

  11. Cappelli C, Castellano M, Braga M et al (2007) Aggressiveness and outcome of papillary thyroid carcinoma (PT C) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol 95:555–560

    Article  PubMed  CAS  Google Scholar 

  12. Ito Y, Miyauchi A, Inoue H et al (2010) An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34:28–35. doi:10.1007/s00268-009-0303-0

    Article  PubMed  Google Scholar 

  13. Sugitani I, Toda K, Yamada K et al (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222–1231. doi:10.1007/s00268-009-0359-x

    Article  PubMed  Google Scholar 

  14. Lee J, Park JH, Lee CR et al (2013) Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma: comparative analysis after propensity score matching. Thyroid 23:1408–1415

    Article  PubMed  Google Scholar 

  15. Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336–341

    Article  PubMed  Google Scholar 

  16. Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34

    Article  PubMed  Google Scholar 

  17. Castillo JJ, Dalia S, Pascual SK (2010) Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies. Blood 116:2897–2907

    Article  PubMed  CAS  Google Scholar 

  18. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605

    Article  PubMed  Google Scholar 

  19. Langan D, Higgins JPT, Gregory W et al (2012) Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. J Clin Epidemiol 65:511–519

    Article  PubMed  Google Scholar 

  20. Lau J, Ioannidis JPA, Terrin N et al (2006) The case of the misleading funnel plot. BMJ 333:597–600

    Article  PubMed  PubMed Central  Google Scholar 

  21. Pedrazzini L, Baroli A, Marzoli L et al (2013) Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinol 38:269–279

    PubMed  CAS  Google Scholar 

  22. Mihailovic J, Stefanovic L, Stankovic R (2013) Influence of initial treatment on the survival and recurrence in patients with differentiated thyroid microcarcinoma. Clin Nucl Med 38:332–338

    Article  PubMed  Google Scholar 

  23. Kim HJ, Kim NK, Choi JH et al (2013) Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma. Clin Endocrinol 78:614–620

    Article  Google Scholar 

  24. Riss JC, Peyrottes I, Chamorey E et al (2012) Prognostic impact of tumour multifocality in thyroid papillary microcarcinoma based on a series of 160 cases. Eur Ann Otorhinolaryngol Head Neck Dis 129:175–178

    Article  PubMed  Google Scholar 

  25. Gershinsky M, Barnett-Griness O, Stein N et al (2012) Total versus hemithyroidectomy for microscopic papillary thyroid cancer. J Endocrinol Invest 35:464–468

    PubMed  CAS  Google Scholar 

  26. Neuhold N, Schultheis A, Hermann M et al (2011) Incidental papillary microcarcinoma of the thyroid—further evidence of a very low malignant potential: a retrospective clinicopathological study with up to 30 years of follow-up. Ann Surg Oncol 18:3430–3436

    Article  PubMed  Google Scholar 

  27. Moon HJ, Kim EK, Chung WY et al (2011) Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?[J]. Ann Surg Oncol 18:1916–1923

    Article  PubMed  Google Scholar 

  28. Mercante G, Frasoldati A, Pedroni C et al (2009) Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19:707–716

    Article  PubMed  CAS  Google Scholar 

  29. Pisanu A, Reccia I, Nardello O et al (2009) Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J Surg 33:460–468. doi:10.1007/s00268-008-9870-8

    Article  PubMed  Google Scholar 

  30. Kim TY, Hong SJ, Kim JM et al (2008) Prognostic parameters for recurrence of papillary thyroid microcarcinoma. BMC Cancer 8:296–307

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hay ID, Hutchinson ME, Gonzalez-Losada T et al (2008) Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery 144:980–988

    Article  PubMed  Google Scholar 

  32. Gülben K, Berberoğlu U, Çelen O et al (2008) Incidental papillary microcarcinoma of the thyroid—factors affecting lymph node metastasis. Langenbecks Arch Surg 393:25–29

    Article  PubMed  Google Scholar 

  33. Pelizzo MR, Boschin IM, Toniato A et al (2006) Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol 32:1144–1148

    Article  PubMed  CAS  Google Scholar 

  34. Cheema Y, Olson S, Elson D et al (2006) What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? J Surg Res 134:160–162

    Article  PubMed  Google Scholar 

  35. Lo CY, Chan WF, Lang BHH et al (2006) Papillary microcarcinoma: is there any difference between clinically overt and occult tumors. World J Surg 30:759–766. doi:10.1007/s00268-005-0363-8

    Article  PubMed  Google Scholar 

  36. Roti E, Rossi R, Trasforini G et al (2006) Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171–2178

    Article  PubMed  CAS  Google Scholar 

  37. Chow SM, Law SCK, Chan JKC et al (2003) Papillary microcarcinoma of the thyroid—prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40

    Article  PubMed  Google Scholar 

  38. Appetecchia M, Scarcello G, Pucci E et al (2002) Outcome after treatment of papillary thyroid microcarcinoma. J Exp Clin Cancer Res 21:159–164

    PubMed  CAS  Google Scholar 

  39. Baudin E, Travagli JP, Ropers J et al (1998) Microcarcinoma of the thyroid gland. Cancer 83:553–559

    Article  PubMed  CAS  Google Scholar 

  40. Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407

    PubMed  PubMed Central  Google Scholar 

  41. Zhang L, Wei WJ, Ji QH et al (2012) Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J Clin Endocrinol Metab 97:1250–1257

    Article  PubMed  CAS  Google Scholar 

  42. Xing M, Haugen BR, Schlumberger M (2013) Progress in molecular-based management of differentiated thyroid cancer. Lancet 381:1058–1069

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  43. Nucera C, Pontecorvi A (2012) Clinical outcome, role of BRAFV600E, and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? Front Endocrinol 3:33

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the helpful methodological advice of Dr. Xiaochun Chou (Shanghai Jiao Tong University).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hongwei Zhang.

Ethics declarations

Conflicts of interest

Authors declare that there are no conflicts, either perceived or real, with respect to this article.

Additional information

Guangfu Hu and Wei Zhu have contributed equally to this work and co-first authors.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 2325 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hu, G., Zhu, W., Yang, W. et al. The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis. World J Surg 40, 100–109 (2016). https://doi.org/10.1007/s00268-015-3346-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-015-3346-4

Keywords

Navigation